|
GNPAT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.161000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.352800E-01 |
| Normal-vs-Stage2 |
1.861190E-01 |
| Normal-vs-Stage3 |
2.845400E-01 |
| Normal-vs-Stage4 |
7.253200E-01 |
| Stage1-vs-Stage2 |
6.975700E-02 |
| Stage1-vs-Stage3 |
3.704000E-01 |
| Stage1-vs-Stage4 |
9.313600E-01 |
| Stage2-vs-Stage3 |
4.480000E-02 |
| Stage2-vs-Stage4 |
1.315050E-01 |
| Stage3-vs-Stage4 |
4.933600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.688800E-01 |
| Normal-vs-AfricanAmerican |
4.209800E-04 |
| Normal-vs-Asian |
6.474800E-01 |
| Caucasian-vs-AfricanAmerican |
4.38209999999994E-05 |
| Caucasian-vs-Asian |
7.156200E-01 |
| AfricanAmerican-vs-Asian |
2.411800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.509200E-01 |
| Normal-vs-Female |
7.291000E-01 |
| Male-vs-Female |
9.389200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.813800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.553400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.162600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.996000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.948600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.734600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.138400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.502600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.824800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.670000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.672400E-01 |
| Normal-vs-Grade 2 |
9.527200E-01 |
| Normal-vs-Grade 3 |
8.781400E-01 |
| Normal-vs-Grade 4 |
7.903500E-02 |
| Grade 1-vs-Grade 2 |
4.063800E-01 |
| Grade 1-vs-Grade 3 |
3.434000E-01 |
| Grade 1-vs-Grade 4 |
4.420200E-02 |
| Grade 2-vs-Grade 3 |
8.110000E-01 |
| Grade 2-vs-Grade 4 |
4.698100E-02 |
| Grade 3-vs-Grade 4 |
8.926300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.404100E-03 |
| Normal-vs-ccB subtype |
4.475600E-02 |
| ccA subtype-vs-ccB subtype |
9.10599999959238E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.014000E-01 |
| Normal-vs-N1 |
4.670800E-01 |
| N0-vs-N1 |
3.985800E-01 |
|
|
